This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
I think I read in several posts down that one a big one is beginning in Aug. I will see if I can find it and get back.
WWW.clinicaltrials.gov
It shows what trials our ongoing. Best to you
I received the following e-mail this morning from Vertex.
Thank you for your recent email inquiring about the clinical trials for
Vertex's VX-950 compound, being developed for the treatment of
chronic Hepatitis C.
A Phase 1b study is in progress in Europe, and a Phase 2 study will be
initiated in the US by the end of 2006; however, these are small
studies that will recruit subjects from their own clinics. The larger
Phase 2 multi-center study will start in the United States in early
2006. The location of clinical sites is being finalized now. This
study will include patients who are "treatment-naïve", meaning
that they have not had prior treatment for hepatitis C. We expect to
conduct additional studies in patients who have not responded to prior
therapy, but have not yet initiated these studies.
The Vertex web site (www.vrtx.com) is the best source of current
information on the status of the next study. As the start of the next
study nears, the web site will include instructions about how to get
contact information for a participating clinical center. You can also
call us, starting at 617-444-6777; we expect to have the site
information in June of 2006.
We appreciate your interest in Vertex and in VX-950, and the time you
have taken to write to us and to provide your information. You can
also follow the Vertex website (www.vrtx.com) which will have the most
up-to-date news about the status of all of our investigational
compounds and clinical studies.
We wish you well with your medical care. Thank you again for your
interest and your continued support of Vertex.
Best regards,
Clinical Development Staff
Vertex Pharmaceuticals Incorporated
RON
I hope everyone had a good weekend.
PDilly, I guess I will need to wait and see what the specialist says when I go back on the 22nd of June. At our first visit, he said there was going to be a study coming up at Duke this summer. He went on to say that maybe I could get in the study. I don't know which one he was talking about. Something about Interferon along with some enzyme. I had the my ultrasound already, but not my biopsy yet I spoke with his PA and she said they don't set up the biopsy until after veiwing all the bloodwork results to see if the paitent even qualifys for one. I definately want one.
Upbeat,
Thanks for posting the info on the study.
Hi Can-Do-Man,
I hope you are doing well. :)
Pam
Hope everyone had a wonderful weekend.
WWW.clinicaltrials.gov
Good luck with the biopsy on Thursday. Please keep us all posted.
Can-Do-Man,
I am glad your day was better. :)
I woke up nervous again, but I got out of bed, weeded the garden, rode the mountain bike 14 miles and swam. The awful nevousness about the unknown just left me. Thank god!! The condition of my liver will be what it is going to be. I just have to take good care of myself and have faith.
My primary care already diagnosed me first as having the antibody to Hep-C, and then the actual virus along with the geno type of 1A.
She said this would be discussed at the next visit.
Glad you went out today, keeping busy keeps the mind from wondering.
My scans did turn out fine. The tech said if he didn't know from my chart that I had Hep, he wouldn't know by looking at the scan. He showed me the blood flowing through it. My spleen and kidneys all looked fine, too.
My ALT was elevated during my routine physical...It was 48. When the doc ran more test, which included the Hep-C antibody, he checked the ALT again, and it was 24.
Have you had a scan done?
Actually, it would probably be good to wait until the end of summer to start treatment if possible.
here are some possible things to read:
http://www.wsaw.com/news/features/1/2744796.html
http://www.healthlit.org/scienceInside/eb_biomedresearch.htm
http://www.annescancer.ca/clinical_trials.html
http://www.vpharm.com/Pressreleases2006/pr052306.html
Recent thread with some discussion:
http://www.medhelp.org/forums/Hepatitis/messages/40952.html
Vertex Webcast: http://www.vpharm.com/
(takes 30-60 minutes to listen to)
-------------------------------------------
Regarding some concerns and points made, but please double-check with Vertex release and webcast above --
1)Initial trials for treatment naive.
2)Trials for non-responders projected for second half of 2007. (Phase IIb study)
3) No one will receive just a placebo. However, intially, one arm will substitute a placebo for Vertex, meaning treatment would be peg and ribavirin.
4)Depending on results of Phase II studies, the Vertex placebo arm could be dropped for Phase III projected for mid-2007.
5) There will be a Peg and Vertex arm only (no ribavirin) but for now that is only planned for the European study.
6) It does not appear that slow responders will be dropped, at least as defined here (in terms of RVR) from above referenced release:
..." As in the PROVE 1 study, patients in the 12 and 24-week treatment arms who achieve a rapid viral response (RVR) defined as undetectable (less than 10 IU/mL) viral levels by the end of week 4, and who maintain this status through to either week 10 or 20 respectively, will stop all treatment at the 12 or 24-week time point and will be followed post-treatment to evaluate whether they achieve SVR. Patients in these treatment arms who do not meet the RVR criterion will continue on peg-IFN and RBV for a total duration of 48 weeks. The 24-week treatment arm will evaluate whether 12 weeks of additional treatment with peg-IFN and RBV adds substantially to the SVR rate compared to 12 weeks of VX-950 in combination with peg-IFN and RBV."
###
Vertex says....Trials for non-responders projected for second half of 2007... 'Projected is the key word there.' What happens when they add the ribavirin? Will they use rescue drugs?
you said... It does not appear that slow responders will be dropped, at least as defined here (in terms of RVR) from above referenced release:...... But could happen right? and when they add the ribavirin what happen if you have a quick drop in your hgb? They either lower the dose, boot you out, or use rescue drugs. Which most don't. And has vertex said they will?
Just think someone one with little or no damage should NOT jump right in the early trials and make their self tx naive. While this drug looks good now as you know lots can happen.
On another note , I would love to go to the ACL Festival in September , but it looks like they only have 3 day passes for sale , I doubt I could hang that long. I saw that Cliff Antone died , Shame , the guy really did alot for the Austin music scene.
Take care ,
52tele
He knows from experience. He pointed to a piece of paper on his wall that had a Phase 3 HIV drug he had about 20 or so of his patients on that just collapsed when it got to the FDA. Whole thing scrapped, millions down the drain.
He did say that in 5 years better drugs will come down the pipe...It is almost a certainty. but for me and my situation I needed to focus on what is at hand insterad of worrying so much about making it to VX-950. (I had bought 40 shares of VRTX stock hopping it does cure all and my stock will pay for the medication..lol...Im still kind of hoping that will happen, even though I've lost 25 cents a share just today)
52tele: Yea, this looks like the best year for ACL fest in a long time. Antone did die young thats for sure. Definately a bummer. A lot of austin's greatness was originally from Dallas!(Vaughn Brothers) Hopefully everything will be fine next week with bx.
Wasn't trying to make a point per se or contradict anything you said. Simply wanted to add more information/references regarding the Vertex trials.
CDM... In my post i has said i did not think vertex was one using a placebo.
Again, not contradicting anything you said, just wanted to expand/clarify that they are using a placebo in the sense that early trials will placebo the Vertex component, while still using peg and riba. Later they might drop the placebo component if things pan out. This is different from using a 100% placebo arm where someone gets only placebo and no drugs.
CDM: Are you saying someone with little or no damage that has time to wait jump right in the early trials, shouldn't they wait for vertex to prove them selfs more?
I did not make that point in my post. But personally, if I had little or no liver damage, yes, I'd wait until Vertex proves itself in the trials. That way, I'd have both more data to consider as well as be able to have my treatment personalized regarding dosing, length, real-time blood test results, rescue drugs, etc.
CDM: Vertex says....Trials for non-responders projected for second half of 2007... 'Projected is the key word there.' What happens when they add the ribavirin? Will they use rescue drugs?
Yes, "projected" but so far they seem to be moving along on schedule. I believe they are using ribavirin in all the intial American trials. Only one European arm will be without ribavirin. I have no idea what their policy will be regarding rescue drugs such as ribavirin, nuprogen, etc. That's another advantage of waiting until a drug comes to market.
CDM: you said... It does not appear that slow responders will be dropped, at least as defined here (in terms of RVR) from above referenced release:...... But could happen right?
According to what I read, those that do not RVR will not be dropped. Instead their treatment will be extended longer. I don't know what their policy is regarding conventional benchmarks such as two-log drop, etc. However, based on data from the initial small trials, most people should get at least a two-log drop -- actually be non-detectible by 12 weeks. In any event, it's a good question, and anyone who's thinking about a trial should try and get hold of the exact trial protocol, or at least call/email Vertex for clarification.
CDM: ...and when they add the ribavirin what happen if you have a quick drop in your hgb? They either lower the dose, boot you out, or use rescue drugs. Which most don't. And has vertex said they will?
Don't think that was covered in release. Again, a good question for Vertex.
CDM:
Just think someone one with little or no damage should NOT jump right in the early trials and make their self tx naive.
Again, I agree. And personally I don't think a person with little or no liver damage should treat with any drug. But others have a different view.
CDM: While this drug looks good now as you know lots can happen.
Yup. And I guess that's why they are called "trials". Still, looks promising so far. Certainly hope so for everyone's sake.
-------
What you didn't ask, but possibly alluded to, is who should do the Vertex trials?
We both agree that those with little or no liver damage should wait. That said, some folks might not agree with you and I :) --
and therefore want to treat with little or no liver damage. I think entering the Vertex trial might be reasonable for this category, since treatment/exposure could end up being less, plus it it doesn't work out, they have time to watch and wait. Also, those with more liver damage might also want to take a chance with the trials after considering the risks versus awards of the Vertex trials against conventional treatment. And, then of course, there are the projected trials for relapsers in early 2007. Should I relsapse, depending on my biopsy result and how the preliminary data flows in, I might be interested in entering one of those trials. Frankly, don't think I have another year of treating with peg and riba in me.
Hope this finds you relatively well.
-- Jim
-- Ji
Ron
If i was able to join one of these trials and wanted to i would at least wait till the end of this year. I feel by then alot more will be known on how this drug will pan out.
Should add i hope these drugs work out for everyone that has hep-c.
There are a LOT of different trials going on right now not JUST the Vertex. If you are dead set against doing the Interferon/Riba waiting for the Vertex makes no sense to me since right now as I understand it is Interferon/Riba and Vertex that is being tested with the best response right?
While the drug does seem promising...
As Ohgreat said:
Phase 3 HIV drug he had about 20 or so of his patients on that just collapsed when it got to the FDA. Whole thing scrapped, millions down the drain.
Remember the press releases are written BY the company (even if they are picked up and REWRITTEN to an article) to drive the stock.
I mean it would be worth trying the Int/Riba combo and see if that killed it first wouldn't it? Until I knew I wouldn't be dying to add yet MORE meds in...enough is enough and by the time you are actually ON treatment you'll find...it's way more than just the "treatment" that you will be on.
Yowza...pill after pill after shot upon shot. Enuff!
Mild Liver damage should not be the main consideration for waiting, because hep c is not just a liver disease. It is a blood disease. Every organ fed by blood flow might get affected by the substances released by the presence of the virus. Already there is connection bt cognitive function, diabetes, renal dysfunction, neuropathy, to name a few and hep c. You do not have to experience severe liver damage to be a victim of extra hepatic symptoms. Your quality of life with hep c, your insurance, your age, support, type of job, all those things should have a prominent place in the decission making, not just the liver bx results. People with mild damage should have the same opportunity(as stage 3 amd 4) to rid themselves of HCV, should they choose that path after learning all they can about tx.
I opted for tx, at stage one, after considering many factors, with the advantage that I could stop and wait should the tx prove to be too much for me, or I did not respond to it. I had to try, and glad I did. No regrets.